TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies
Top Cited Papers
Open Access
- 1 September 2025
- journal article
- review article
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-12
Abstract
TIGIT immune checkpoint (IC) has attracted great interest in recent years. It belongs to the PVR-like protein family, and it inhibits T and NK cell cytotoxic activities. TIGIT mediates its inhibitory effect by direct signaling through the cytoplasmic tail, CD155-mediated inhibition, or competition with the immune-activating receptor CD226. Preclinical observations from studies involving TIGIT-specific blocking monoclonal antibodies (mAbs) are promising, but the results of the clinical trials using anti-TIGIT mAb monotherapy were not favorable, which prompted a focus on combinational therapies. Some alternative approaches have the potential to avoid limitations, including low penetration, immunogenicity and safety of mAbs. This review addresses the mechanisms underlying TIGIT-mediated immune suppression. Additionally, promising immunotherapeutic approaches against TIGIT, including co-inhibition of TIGIT with other ICs, using small molecule inhibitors, blocking the TIGIT/PVR pathway using CAR-T cells and the current state of clinical trials as well as future directions, are discussed.Keywords
This publication has 117 references indexed in Scilit:
- The TIGIT/CD226 Axis Regulates Human T Cell FunctionThe Journal of Immunology, 2012
- Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell–cell adhesion and signaling mechanism that requires cis-trans receptor clusteringProceedings of the National Academy of Sciences, 2012
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory FunctionsThe Journal of Immunology, 2011
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityProceedings of the National Academy of Sciences, 2009
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cellsNature Immunology, 2008
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- CD226 (DNAM-1) Is Involved in Lymphocyte Function–associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and ProliferationJournal of Experimental Medicine, 2003
- GSK-3: tricks of the trade for a multi-tasking kinaseJournal of Cell Science, 2003
- CD28 Costimulation Mediates Down-Regulation of p27kip1 and Cell Cycle Progression by Activation of the PI3K/PKB Signaling Pathway in Primary Human T CellsThe Journal of Immunology, 2002
- An overview of the immune systemThe Lancet, 2001